Orange Book product · Generic (ANDA)
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
At a glance
Jun 16, 1988
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 16, 1988
38 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
Strength
0.5%;0.005MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 071170
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
- 1988BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 071165 · HOSPIRA
- 1988BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 071166 · HOSPIRA
- 1988BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 071167 · HOSPIRA
- 1988BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 071168 · HOSPIRA
- 1988BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 071169 · HOSPIRA
- 1988BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 071171 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
